Lundbeck releases transcript of H1 2026 earnings call
- H. Lundbeck hosted its H1 2026 earnings call with CEO Charl van Zyl, EVP Thomas Gibbs, EVP Michala Fischer Hansen, CFO Joerg Hornstein, R&D head Johan Luthman, incoming R&D head Tarek Samad.
- Guidance maintained: revenue growth 7%-9% at constant exchange rates; adjusted EBITDA growth 8%-14%; CFO flagged H2 normalization from inventory phasing.
- H1 revenue DKK 13.6 billion, up 16% at constant exchange rates; adjusted EBITDA up 19%; net debt cut to DKK 7.4 billion.
- Vyepti H1 revenue DKK 2.87 billion, up 46%; US demand up 41.3%; US share hit 13.01%, surpassing Aimovig.
- Pipeline focus: bexicaserin DEEp OCEAN readout due Q4 2026; DEEp SEA randomization targeted mid-September; bocunebart Phase III start planned 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. H. Lundbeck A/S published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now